Bachem Holding AG
BANB
Clasificación en acciones
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Precio por acción
$100.60
Capitalización bursátil
$7.54B
Cambio (1 día)
-1.49%
Cambio (1 año)
49.53%
País
CH
Comercio Bachem Holding AG (BANB)
Categoría
Healthcare
Ratio P/S de Bachem Holding AG (BANB)
Ratio P/S al October 2026 TTM: 8.79
Según los informes financieros más recientes y el precio de las acciones de Bachem Holding AG, el ratio P/S actual (TTM) es 8.79. Al final de 2024, el ratio P/S era 7.17.
Historial del ratio P/S de Bachem Holding AG desde 2002 hasta 2026
Ratio P/S al final de cada año
| Año | Ratio P/S | Cambiar |
|---|---|---|
| 2026 (TTM) | 8.79 | 36.05% |
| 2025 | 6.46 | -9.93% |
| 2024 | 7.17 | -14.70% |
| 2023 | 8.41 | -24.05% |
| 2022 | 11.07 | -45.08% |
| 2021 | 20.16 | 46.39% |
| 2020 | 13.77 | 101.70% |
| 2019 | 6.83 | 23.90% |
| 2018 | 5.51 | -31.03% |
| 2017 | 7.99 | 54.45% |
| 2016 | 5.17 | 53.63% |
| 2015 | 3.37 | -6.48% |
| 2014 | 3.60 | -6.15% |
| 2013 | 3.84 | 23.05% |
| 2012 | 3.12 | 3.81% |
| 2011 | 3.00 | -39.11% |
| 2010 | 4.93 | 0.55% |
| 2009 | 4.91 | -11.37% |
| 2008 | 5.53 | -13.64% |
| 2007 | 6.41 | -9.30% |
| 2006 | 7.07 | -78.19% |
| 2005 | 32.39 | 454.09% |
| 2004 | 5.85 | 2,412.38% |
| 2003 | 0.23 | 12,827.78% |
| 2002 | 0.00 | 0.00% |
Ratio P/S de empresas similares o competidoras
| Empresa | Ratio P/S | Diferencia del ratio P/S | País |
|---|---|---|---|
| 10.02 | 14.03% |
US
|
|
| 40.55 | 361.39% |
US
|
|
| 4.19 | -52.32% |
AU
|
|
| 10.44 | 18.82% |
NL
|
|
| - | - |
CH
|
